Download PDF
Semin intervent Radiol
DOI: 10.1055/s-0045-1812084
Review Article

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes

Authors

  • Lynden Lee

    1   Division of Interventional Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California

  • Siyuan Cao

    2   Division of Pulmonary Critical Care, David Geffen School of Medicine at UCLA, Los Angeles, California

  • Conrad B. Miles

    3   Department of Radiology, Section of Interventional Radiology, University of California, San Francisco, California

  • Michael P. Troy

    2   Division of Pulmonary Critical Care, David Geffen School of Medicine at UCLA, Los Angeles, California

  • John M. Moriarty

    1   Division of Interventional Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California
Further Information
Also available at
   Permissions and Reprints

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive condition characterized by persistent thromboembolic disease in the pulmonary arteries, leading to increased pulmonary vascular resistance and right heart failure. Medical therapy offers symptomatic relief but is not curative. Pulmonary thromboendarterectomy (PTE) remains the gold standard treatment; however, patients are often ineligible for surgery due to unfavorable anatomy, comorbidities, or preferences.

Balloon pulmonary angioplasty (BPA) has emerged as a minimally invasive alternative, particularly for patients with inoperable CTEPH or post-PTE patients who remain symptomatic. Balloon catheters are used to dilate stenotic pulmonary arteries and to disrupt intraluminal webs and synechia, improving hemodynamics and leading to better quality of life. Careful patient selection for BPA is crucial, requiring a multidisciplinary approach to identify suitable candidates. Although BPA has demonstrated favorable outcomes, challenges remain in optimizing procedural techniques, reducing complication rates, and establishing standardized treatment protocols.

This work aims to review BPA and its role in treating CTEPH, from patient selection to expected outcomes, as well as potential areas of future research, which includes the need for increased awareness and accessibility to specialized CTEPH centers, advancements in imaging technology, procedural standardization, and investigation of combination therapies to further support BPA efficacy and improve patient outcomes.

Keywords

balloon pulmonary angioplasty - chronic thromboembolic pulmonary hypertension - pulmonary embolism - interventional radiology - angioplasty


Publication History

Article published online:
24 October 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA